Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia Coli

Overview

Journal Mol Biotechnol

Publisher Springer

Specialties Biotechnology
Molecular Biology

Date 2017 Mar 22

PMID 28324209

Citations 3

Authors

Naphatsamon Uthailak

Pornpimol Mahamad

Pamorn Chittavanich

Somchai Yanarojana

Wassana Wijagkanalan

Jean Petre

Watanalai Panbangred

Affiliations

Soon will be listed here.

Abstract

CRM197 is a diphtheria toxin (DT) mutant (G52E) which has been used as a carrier protein for conjugate vaccines. However, it still possesses cytotoxicity toward mammalian cells. The goal of this project was to produce a non-toxic and soluble CRM197EK through introduction of triple amino acid substitutions (K51E/G52E/E148K) in Escherichia coli. The expression of CRM197EKTrxHis was optimized and co-expressed with different molecular chaperones. The soluble CRM197EKTrxHis was produced at a high concentration (97.33 ± 17.47 μg/ml) under the optimal condition (induction with 0.1 mM IPTG at 20 °C for 24 h). Cells containing pG-Tf2, expressing trigger factor and GroEL-GroES, accumulated the highest amount of soluble CRM197EKTrxHis at 111.24 ± 10.40 μg/ml after induction for 24 h at 20 °C. The soluble CRM197EKTrxHis still possesses nuclease activity and completely digest λDNA at 25 and 37 °C with 8- and 4-h incubation, respectively. Molecular modeling of diphtheria toxin, CRM197 and CRM197EK indicated that substitutions of two amino acids (K51E/E148K) may cause poor NAD binding, consistent with the lack of toxicity. Therefore, CRM197EK might be used as a new potential carrier protein. However, further in vivo study is required to confirm its roles as functional carrier protein in conjugate vaccines.

Citing Articles

High-Level Production of Soluble Cross-Reacting Material 197 in Cytoplasm Due to Fine Tuning of the Target Gene's mRNA Structure.

Khodak Y, Ryazanova A, Vorobiev I, Kovalchuk A, Ovechko N, Aparin P BioTech (Basel). 2023; 12(1).

PMID: 36648835 PMC: 9844443. DOI: 10.3390/biotech12010009.

A Review: Molecular Chaperone-mediated Folding, Unfolding and Disaggregation of Expressed Recombinant Proteins.

Fatima K, Naqvi F, Younas H Cell Biochem Biophys. 2021; 79(2):153-174.

PMID: 33634426 DOI: 10.1007/s12013-021-00970-5.

Oligomerization of a molecular chaperone modulates its activity.

Saio T, Kawagoe S, Ishimori K, Kalodimos C Elife. 2018; 7.

PMID: 29714686 PMC: 5988418. DOI: 10.7554/eLife.35731.

References

Studier F, Daegelen P, Lenski R, Maslov S, Kim J . Understanding the differences between genome sequences of Escherichia coli B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 genomes. J Mol Biol. 2009; 394(4):653-80. DOI: 10.1016/j.jmb.2009.09.021. View

Pecetta S, Vijayakrishnan B, Romano M, Proietti D, Lo Surdo P, Balocchi C . Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines. Vaccine. 2016; 34(11):1405-11. DOI: 10.1016/j.vaccine.2016.01.040. View

Duan Y, Wu C, Chowdhury S, Lee M, Xiong G, Zhang W . A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem. 2003; 24(16):1999-2012. DOI: 10.1002/jcc.10349. View

Prinz W, Aslund F, Holmgren A, Beckwith J . The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J Biol Chem. 1997; 272(25):15661-7. DOI: 10.1074/jbc.272.25.15661. View

Perera V, Corbel M . Human antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141-157 of fragment A. Epidemiol Infect. 1990; 105(3):457-68. PMC: 2271834. DOI: 10.1017/s095026880004807x. View

Rabhi-Essafi I, Sadok A, Khalaf N, Fathallah D . A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng Des Sel. 2007; 20(5):201-9. DOI: 10.1093/protein/gzm012. View

Deng Q, Barbieri J . Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol. 2008; 62:271-88. DOI: 10.1146/annurev.micro.62.081307.162848. View

Bruce C, Baldwin R, Lessnick S, Wisnieski B . Diphtheria toxin and its ADP-ribosyltransferase-defective homologue CRM197 possess deoxyribonuclease activity. Proc Natl Acad Sci U S A. 1990; 87(8):2995-8. PMC: 53820. DOI: 10.1073/pnas.87.8.2995. View

Qiao J, Ghani K, Caruso M . Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity. Toxicon. 2007; 51(3):473-7. DOI: 10.1016/j.toxicon.2007.09.010. View

10.

Zhou J, Petracca R . Secretory expression of recombinant diphtheria toxin mutants in B. Subtilis. J Tongji Med Univ. 2003; 19(4):253-6. DOI: 10.1007/BF02886955. View

11.

Hendrick J, Hartl F . Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 1993; 62:349-84. DOI: 10.1146/annurev.bi.62.070193.002025. View

12.

Vera A, Gonzalez-Montalban N, Aris A, Villaverde A . The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng. 2006; 96(6):1101-6. DOI: 10.1002/bit.21218. View

13.

Bishai W, Rappuoli R, Murphy J . High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli. J Bacteriol. 1987; 169(11):5140-51. PMC: 213919. DOI: 10.1128/jb.169.11.5140-5151.1987. View

14.

Malito E, Bursulaya B, Chen C, Lo Surdo P, Picchianti M, Balducci E . Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197. Proc Natl Acad Sci U S A. 2012; 109(14):5229-34. PMC: 3325714. DOI: 10.1073/pnas.1201964109. View

15.

Uchida T, PAPPENHEIMER Jr A, Greany R . Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J Biol Chem. 1973; 248(11):3838-44. View

16.

Kageyama T, Ohishi M, Miyamoto S, Mizushima H, Iwamoto R, Mekada E . Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity. J Biochem. 2007; 142(1):95-104. DOI: 10.1093/jb/mvm116. View

17.

Broker M, Costantino P, DeTora L, McIntosh E, Rappuoli R . Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications. Biologicals. 2011; 39(4):195-204. DOI: 10.1016/j.biologicals.2011.05.004. View

18.

Raju R, Navaneetham D, Okita D, McCormick D, Conti-Fine B . Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects. Eur J Immunol. 1995; 25(12):3207-14. DOI: 10.1002/eji.1830251202. View

19.

Martinez-Alonso M, Garcia-Fruitos E, Ferrer-Miralles N, Rinas U, Villaverde A . Side effects of chaperone gene co-expression in recombinant protein production. Microb Cell Fact. 2010; 9:64. PMC: 2944165. DOI: 10.1186/1475-2859-9-64. View

20.

Bell C, Eisenberg D . Crystal structure of nucleotide-free diphtheria toxin. Biochemistry. 1997; 36(3):481-8. DOI: 10.1021/bi962214s. View